Liver-type Fatty Acid-Binding Protein (L-FABP) primarily synthesized from the liver and also produced in other organs such as the kidney, can measured in urine to forecast the occurrence of AKI in patients who have undergone cardiac surgery or those in critical condition, with an apparent advantage over NGAL. This evidence concerns the gene FABP1 and acute kidney injury.